High Artificial Sweetener Intake in Pregnancy Linked to Increased Risk of Gestational Diabetes: Study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-05-25 14:45 GMT   |   Update On 2025-05-25 14:45 GMT

China: A recent study published in Diabetes, Metabolic Syndrome and Obesity examined the relationship between artificial sweetener consumption and the risk of gestational diabetes mellitus (GDM) in pregnant women. The findings revealed that women consuming high levels of sweeteners such as sucralose, aspartame, and sodium saccharin had a 56.9% incidence of GDM, compared to 43.1% in the low-consumption group.              

Advertisement

The study found that high consumption of these sweeteners was associated with an increased risk of GDM (OR 2.66), particularly among women with higher body mass indices (BMI) and younger age.

Gestational diabetes mellitus is a condition that arises during pregnancy and is often associated with poor dietary habits. It can lead to complications such as preeclampsia, premature delivery, and an increased likelihood of the mother developing type 2 diabetes later in life. As food processing evolves, more pregnant women are consuming artificial sweeteners, with sucralose, aspartame, and sodium saccharin being the most common. This has raised concerns about whether the consumption of these sweeteners during pregnancy could increase the risk of GDM.

Against the above background, Li Huang, School of Nursing, Guangdong Pharmaceutical University, Guangzhou, People’s Republic of China, and colleagues explored the relationship between artificial sweetener consumption during pregnancy and the incidence of GDM.

For this purpose, the researchers surveyed 422 pregnant women from a hospital in Guangdong to assess their consumption of artificial sweeteners and other factors related to gestational diabetes mellitus. GDM was diagnosed using the 75g oral glucose tolerance test (OGTT) at any stage of pregnancy, following the guidelines of the International Association of Diabetes and Pregnancy Study Groups (IADPSG). Based on a four-point scale, participants were grouped into low and high artificial sweetener consumption categories.

A multifactorial logistic regression model was then applied to control for potential confounders and evaluate the association between sweetener intake and GDM risk.

Key Findings:

  • The study involved 422 pregnant women with a mean age of 32 years, and the overall incidence of gestational diabetes mellitus (GDM) was 13.74%.
  • GDM incidence was significantly higher among women with high artificial sweetener consumption (56.90%) than those with low consumption (43.10%).
  • High intake of artificial sweeteners was associated with an increased risk of GDM, with an odds ratio (OR) of 2.66.
  • The link between higher sweetener consumption and GDM remained evident even after BMI-stratified analysis, indicating BMI as a contributing factor.

Based on findings, the researchers suggest that excessive intake of artificial sweeteners—such as sucralose, aspartame, and sodium saccharin—during pregnancy is associated with a higher risk of developing gestational diabetes mellitus (GDM). They emphasized the need for more evidence-based dietary guidelines and increased awareness regarding artificial sweetener consumption during pregnancy.

“Caution is advised when consuming sugar-free products like beverages, yogurt, ice cream, and pastries,” they noted.

They concluded, “Further research, including clinical and experimental studies, is essential to better understand the underlying mechanisms and to support healthier dietary choices for pregnant women.”

Reference:

Huang L, Huang Y, Zhang H, Lyu C. Correlation Analyses of the Consumption of Artificial Sweeteners During Pregnancy and the Incidence of Gestational Diabetes Mellitus. Diabetes Metab Syndr Obes. 2025;18:1527-1538

https://doi.org/10.2147/DMSO.S513544


Tags:    
Article Source : Diabetes, Metabolic Syndrome and Obesity

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Medical Bulletin 24/May/2025